TY  - CHAP
M1  - Book, Section
TI  - Addition of atezolizumab to FOLFOXIRI and bevacizumab led to limited increase in survival in metastatic colorectal cancer
A1  - Pushani, Johan
A1  - Chan, Samuel
PY  - 2015
T2  - 2 Minute Medicine
AB  - 
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/23
UR  - accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=594487
ER  -